Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials

QR Code

Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were first detected in Wuhan, China in December 2019 and resulted in a worldwide pandemic in 2020. SARS-CoV-2 infections totalled more than 180 million with 3.9 million deaths as of June 24, 2021. Tremendous research efforts hav...

Full description

Bibliographic Details
Main Authors:	Lim, Hui Xuan , Masita, Arip, Abdul Aziz, Al-Fattah Yahaya , Jazayeri, S. D. , Poppema, Sibrandes , Poh, Chit Laa *
Format:	Article
Language:	English
Published:	IMR Press 2021
Subjects:	RA Public aspects of medicine
Online Access:	http://eprints.sunway.edu.my/2171/ http://eprints.sunway.edu.my/2171/1/landmark5024%20%289%29.pdf

Similar Items

Development of multi-epitope peptide-based vaccines against SARS-CoV-2
by: Lim, Hui Xuan *, et al.
Published: (2020)

Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
by: Abdul Aziz, Al-Fattah Yahaya *, et al.
Published: (2023)

The SARS-CoV-2 variants and their impacts
by: Akmal Shukri, Amir Muhaimin, et al.
Published: (2022)

Identification of B-cell epitopes for eliciting neutralizing antibodies against the SARS-CoV-2 spike protein through bioinformatics and monoclonal antibody targeting
by: Lim, Hui Xuan *, et al.
Published: (2022)

Genomic epidemiology of SARS-CoV-2 in Malaysia
by: Chew, Sian Hui
Published: (2025)

Pathophysiology, histopathology and therapeutic of SARS-CoV-2
by: Noman, Efaq, et al.
Published: (2020)

Lateral flow immunoassays for SARS-CoV-2
by: Ang, Geik Yong, et al.
Published: (2022)

In silico selection of aptamers against SARS-CoV-2
by: Akmal Shukri, Amir Muhaimin, et al.
Published: (2024)

Development of universal influenza vaccines targeting conserved viral proteins
by: Jazayeri, S. D. *, et al.
Published: (2019)

Construction of multi-epitopes vaccine candidate against SARS-CoV-2 D614G variant
by: Siti Asmaa Mat Jusoh,, et al.
Published: (2022)

Humoral response to SARS-CoV-2 vaccines among healthcare workers in a tertiary hospital in Malaysia
by: Mohd Amin, Amrina, et al.
Published: (2022)

Recent advances in delivery of veterinary DNA vaccines against avian pathogens
by: Jazayeri, S. D. *, et al.
Published: (2019)

The cell mediated and humoral response to SARS-CoV-2 infection
by: Burns, Eleanor
Published: (2022)

Thermophoretic collection of virus-laden (SARS-CoV-2) aerosols
by: Zhang, Xiangzhi, et al.
Published: (2021)

SARS-CoV-2 screening must go beyond sick
by: Abdullah, Syahril
Published: (2020)

Defining the clinicoradiologic syndrome of SARS-CoV-2 acute necrotizing encephalopathy
by: Lee, Vanessa W., et al.
Published: (2024)

SARS-CoV-2: from origin to treatment and control management strategies
by: Hezam, Kamal, et al.
Published: (2020)

Risk Perceptions of SARS-CoV-2 in the UK: A City-wise Analysis
by: Raza, Naba
Published: (2022)

NK cells: A double edge sword against SARS-CoV-2
by: Masselli, E., et al.
Published: (2020)

Concerns regarding SARS-CoV-2 JN.1 mutations should be raised
by: Roney, Miah, et al.
Published: (2024)

SARS-CoV-2 infection and human semen: possible modes of contamination and transmission
by: Bhattacharya, Koushik, et al.
Published: (2021)

Coronavirus (SARS-COV-2) in early stages of the pandemic; overview
by: Al-Gheethi, Adel, et al.
Published: (2020)

Apa yang berlaku pada tubuh apabila berlaku jangkitan SARS-CoV-2 ?
by: Mohd Nasir, Mohd Hamzah
Published: (2020)

Isolation and characterisation of bovine ultralong antibodies to SARS-CoV-2 using phage display
by: Park, Emily
Published: (2024)

Nano and microparticles as potential oral vaccine carriers and adjuvants against infectious diseases
by: Jazayeri, S. D. *, et al.
Published: (2021)

Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial
by: Pomat, William, et al.
Published: (2013)

A Fog Computing-based System to Identify SARS - CoV -2 Using Deep Learning
by: Welhenge, Anuradhi
Published: (2021)

Identification of SARS-CoV-2 inhibitors from alkaloids using molecular modeling and in silico approaches
by: Roni, Md Abul Hasan, et al.
Published: (2023)

Whole genome sequencing analysis of SARS-CoV-2 from Malaysia: from alpha to Omicron
by: Choo, Yee Yu, et al.
Published: (2022)

Susceptibility to SARS-CoV-2 omicron following ChAdOx1 nCoV-19 and BNT162b2 versus CoronaVac vaccination
by: Chua, Jia Xin, et al.
Published: (2022)

Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1
by: Chan, Lee-Chin, et al.
Published: (2023)

Insights into innate and adaptive immune responses in vaccine development against EV-A71
by: Lim, Hui Xuan *, et al.
Published: (2019)

Development of antivirals and vaccines against enterovirus 71 (EV-A71)
by: Poh, Chit Laa *
Published: (2018)

Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection
by: Romani, Arianna, et al.
Published: (2023)

Maternal immune activation as a risk factor for psychiatric illness in the context of the SARS-CoV-2 pandemic
by: Lins, Brittney
Published: (2021)

Increasing Sporadic Covid-19 Cases:Should We Heed Airborne Transmission Of SARS-CoV-2?
by: Ahmad Mahfuz, Gazali
Published: (2021)

Increasing sporadic Covid-19 cases:should we heed airborne transmission of SARS-CoV-2?
by: Ahmad Mahfuz, Gazali
Published: (2021)

Evolution of SARS-CoV-2 from BA.2.86 to JN.1 variations and detection in Bangladesh
by: Roney, Miah, et al.
Published: (2024)

Survival and disinfection of SARS-Cov-2 in environment and contaminated surface
by: Al-Gheethi, Adel, et al.
Published: (2020)

Virus-like particles of nodavirus displaying the receptor binding domain of SARS-CoV-2 spike protein: a potential VLP-based COVID-19 vaccine
by: Kumar, Kiven, et al.
Published: (2023)